Published in Virchows Arch B Cell Pathol Incl Mol Pathol on January 01, 1987
Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system. Br J Cancer (1999) 2.34
Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice. Nat Genet (2000) 2.26
Cloning and characterization of a second AP-2 transcription factor: AP-2 beta. Development (1995) 1.95
The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor function. Proc Natl Acad Sci U S A (1997) 1.55
Functional implication of BMP4 expression on angiogenesis in malignant melanoma. Oncogene (2006) 1.44
Transforming potential of the adenovirus type 5 E4orf3 protein. J Virol (1999) 1.31
"Hit-and-run" transformation by adenovirus oncogenes. J Virol (2001) 1.29
The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma. Gut (2007) 1.17
Establishment and characterization of the follicular thyroid carcinoma cell line ML-1. J Mol Med (Berl) (2000) 1.15
The nuclear form of phospholipid hydroperoxide glutathione peroxidase is a protein thiol peroxidase contributing to sperm chromatin stability. Mol Cell Biol (2005) 1.15
Computerized determination of growth kinetic curves and doubling times from cells in microculture. Anal Biochem (1990) 1.13
Standardized kinetic microassay to quantify differential chemosensitivity on the basis of proliferative activity. J Cancer Res Clin Oncol (1992) 1.11
Factors affecting proliferation and dedifferentiation of primary bovine oviduct epithelial cells in vitro. Cell Tissue Res (1999) 1.11
Signaling-inactive epidermal growth factor receptor/ligand complexes in intact carcinoma cells by quinazoline tyrosine kinase inhibitors. Cancer Res (2001) 1.09
Potent stimulation of monocytic endothelin-1 production by HIV-1 glycoprotein 120. J Immunol (1993) 1.05
Two distinct activities contribute to the oncogenic potential of the adenovirus type 5 E4orf6 protein. J Virol (2000) 1.04
Role of Mac-1 and ICAM-1 in ischemia-reperfusion injury in a microcirculation model of BALB/C mice. Am J Physiol (1994) 1.04
Can biochemical markers serve as surrogates for imaging in knee osteoarthritis? Arthritis Rheum (2007) 1.03
Angiogenesis in the bovine corpus luteum: an immunocytochemical and ultrastructural study. Anat Histol Embryol (1999) 1.03
Hyaluronidase enhances the activity of adriamycin in breast cancer models in vitro and in vivo. J Cancer Res Clin Oncol (1992) 1.02
Immunocontent and secretion of S100B in astrocyte cultures from different brain regions in relation to morphology. FEBS Lett (2000) 1.00
The adenovirus E4orf6 protein contributes to malignant transformation by antagonizing E1A-induced accumulation of the tumor suppressor protein p53. Oncogene (1999) 1.00
The induction of micronuclei in vitro by unpolymerized resin monomers. J Dent Res (2001) 1.00
A highly sensitive model for quantification of in vivo tumor angiogenesis induced by alginate-encapsulated tumor cells. Cancer Res (1997) 0.99
Gene expression profiling of bovine endometrium during the oestrous cycle: detection of molecular pathways involved in functional changes. J Mol Endocrinol (2005) 0.99
Renal mesangial cell cultures as a model for study of erythropoietin production. Proc Natl Acad Sci U S A (1983) 0.99
Isolation and characterization of endothelial cells from different organs of fetal pigs. Anat Embryol (Berl) (1996) 0.96
The placenta of the pig. I. Finestructural changes of the placental barrier during pregnancy. Anat Embryol (Berl) (1980) 0.94
The antitumor mechanism of progesterone antagonists is a receptor mediated antiproliferative effect by induction of terminal cell death. J Steroid Biochem (1989) 0.91
Pharmacokinetics and tissue distribution of bovine testicular hyaluronidase and vinblastine in mice: an attempt to optimize the mode of adjuvant hyaluronidase administration in cancer chemotherapy. Cancer Lett (1998) 0.91
Embryo-maternal communication in bovine - strategies for deciphering a complex cross-talk. Reprod Domest Anim (2003) 0.90
Growth hormone receptor expression in the nucleus and cytoplasm of normal and neoplastic cells. Histochem Cell Biol (1998) 0.90
Effects of high concentrations of hyaluronan in culture medium on development and survival rates of fresh and frozen-thawed bovine embryos produced in vitro. Reproduction (2002) 0.90
The expression of the IGF family and GH receptor in the bovine mammary gland. J Endocrinol (2001) 0.89
Antiangiogenic chemotherapeutic agents: characterization in comparison to their tumor growth inhibition in human renal cell carcinoma models. Clin Cancer Res (1998) 0.88
The complete primary structure of the spermadhesin AWN, a zona pellucida-binding protein isolated from boar spermatozoa. FEBS Lett (1992) 0.87
Ultrastructural evidence for phagocytosis of spermatozoa in the bovine rete testis and testicular straight tubules. J Reprod Fertil (1979) 0.86
Intertubular topography in the bovine testis. Cell Tissue Res (1981) 0.86
The placenta of the pig. II. The ultrastructure of the areolae. Anat Embryol (Berl) (1981) 0.86
Antiestrogens. Synthesis and evaluation of mammary tumor inhibiting activity of 1,1,2,2-tetraalkyl-1,2 -diphenylethanes. J Med Chem (1980) 0.86
Effects of a novel co-culture system on development, metabolism and gene expression of bovine embryos produced in vitro. Reproduction (2002) 0.85
Reverse lectin histochemistry: design and application of glycoligands for detection of cell and tissue lectins. Histol Histopathol (1993) 0.85
Quantitation of hyaluronidases by the Morgan-Elson reaction: comparison of the enzyme activities in the plasma of tumor patients and healthy volunteers. Cancer Lett (1998) 0.85
Ring-substituted [1,2-bis(4-hydroxyphenyl)ethylenediamine]dichloroplatinum (II) complexes: compounds with a selective effect on the hormone-dependent mammary carcinoma. J Med Chem (1988) 0.85
[Antimicrobial and tumor-inhibiting properties of dithiourethane and studies on the mechanism of action. 16. Cytostatica]. Pharmazie (1972) 0.85
Clinicopathological features of extranodal lymphomas: Kuwait experience. Oncology (2004) 0.85
Oestrogenic and antioestrogenic actions in a series of triphenylbut-1-enes: modulation of prolactin synthesis in vitro. Br J Pharmacol (1986) 0.85
Up-regulation of growth hormone receptor immunoreactivity in human melanoma. Anticancer Res (1999) 0.85
Hyaluronidase significantly enhances the efficacy of regional vinblastine chemotherapy of malignant melanoma. J Cancer Res Clin Oncol (1995) 0.84
Endothelin expression in normal human anterior pituitaries and pituitary adenomas. J Clin Endocrinol Metab (1994) 0.84
Negative cooperativity between alpha 3 beta 1 and alpha 2 beta 1 integrins in human mammary carcinoma MDA MB 231 cells. Exp Cell Res (1998) 0.84
Murine homodimeric adhesion/growth-regulatory galectins-1, -2 and -7: comparative profiling of gene/ promoter sequences by database mining, of expression by RT-PCR/immunohistochemistry and of contact sites for carbohydrate ligands by computational chemistry. Folia Biol (Praha) (2007) 0.83
[The relation between the testicular artery and the veins of the pampiniform plexus in the bull]. Anat Histol Embryol (1987) 0.83
Programmable biodegradable implants. J Control Release (2001) 0.83
Expression and localisation of oestrogen and progesterone receptors in the bovine mammary gland during development, function and involution. J Endocrinol (2003) 0.82
The fine structure of the terminal segment of the bovine seminiferous tubule. Cell Tissue Res (1982) 0.82
The future of antihormone therapy: innovations based on an established principle. J Cancer Res Clin Oncol (1996) 0.82
Expression of cytokeratin 18 during pre- and post-natal porcine lung development. Anat Histol Embryol (2002) 0.82
Establishment and characterization of a human papillary thyroid carcinoma cell line with oxyphilic differentiation (ONCO-DG 1). Virchows Arch B Cell Pathol Incl Mol Pathol (1992) 0.82
Localization and concentration of a new bioactive acetic seminal fluid protein (aSFP) in bulls (Bos taurus). J Reprod Fertil (1993) 0.82
Development of more selective anti-cancer nitrosoureas. Anticancer Drug Des (1988) 0.82
The lamina propria of the bovine seminiferous tubule. Cell Tissue Res (1979) 0.82
Special class placement for conduct problem children. Except Child (1977) 0.82
Insulin-like growth factor-binding protein-4 inhibits growth of the thymus in transgenic mice. J Mol Endocrinol (2004) 0.82
Antitumor activity of the antiprogestins ZK 98.299 and RU 38.486 in hormone dependent rat and mouse mammary tumors: mechanistic studies. Breast Cancer Res Treat (1989) 0.81
Expression and localization of growth factors and their receptors in the mammalian testis. Part I: Fibroblast growth factors and insulin-like growth factors. Anat Histol Embryol (2005) 0.81
[Ultrasound in the early diagnosis of congenital dislocation of the patella]. Z Orthop Ihre Grenzgeb (2002) 0.81
Cyclin D1 protein expression in human thyroid gland and thyroid cancer. Anat Histol Embryol (2006) 0.81
Estrogenic regulation of clusterin mRNA in normal and malignant endometrial tissue. Int J Cancer (1998) 0.81
Extracellular S100B protein modulates ERK in astrocyte cultures. Neuroreport (2000) 0.81
Nitrosoureas. Modes of action and perspectives in the use of hormone receptor affinity carrier molecules. Acta Oncol (1989) 0.81
On the ultrastructure of the canine mammary gland during pregnancy and lactation. J Anat (1980) 0.81
Hyaluronidase pretreatment produces selective melphalan enrichment in malignant melanoma implanted in nude mice. Cancer Chemother Pharmacol (1996) 0.81
Ultrastructural studies on the effect of testosterone, 5alpha-dihydrotestosterone, and 5alpha-androstand-3alpha,17alpha-diol on the canine prostate cultured in vitro. J Ultrastruct Res (1977) 0.81
Developmental changes in the expression of the growth hormone receptor messenger ribonucleic acid and protein in the bovine ovary. Biol Reprod (1998) 0.81
Reporter genes for embryogenesis research in livestock species. Theriogenology (2007) 0.81
Platinum compounds with estrogen receptor affinity. Cancer Treat Rev (1990) 0.81
Endocrine effects of environmental pollution on Xenopus laevis and Rana temporaria. Environ Res (2003) 0.80
Histochemical analysis of glycoconjugates in the skin of a catfish (arius tenuispinis, day). Anat Histol Embryol (2009) 0.80
Immunohistochemical detection of macrophage migration inhibitory factor in fetal and adult bovine epididymis: release by the apocrine secretion mode? Cells Tissues Organs (2006) 0.80
Nonsteroidal antiestrogens and partial estrogens with prostatic tumor inhibiting activity. J Cancer Res Clin Oncol (1986) 0.80
Differential expression of ZPC in the bovine ovary, oocyte, and embryo. Mol Reprod Dev (1998) 0.80
Inhibition of metastasis by cicaprost in rats with established SMT2A mammary carcinoma growth. Cancer Detect Prev (1997) 0.80
Expression of lymphangiogenic vascular endothelial growth factor family members in bovine corpus luteum. Anat Histol Embryol (2012) 0.80
Vitamin D metabolites prevent vertebral osteopenia in ovariectomized rats. Calcif Tissue Int (1992) 0.80
The prostacyclin analogue cicaprost inhibits metastasis of tumours of R 3327 MAT Lu prostate carcinoma and SMT 2A mammary carcinoma. J Cancer Res Clin Oncol (1992) 0.80
The ultrastructure of dog epididymis. Urol Res (1981) 0.80
Indolo[2,1-a]isoquinolines. Syntheses, steroid hormone receptor binding affinities, and cytostatic activity. J Med Chem (1990) 0.80
1,1,2-triphenylbut-1-enes: relationship between structure, estradiol receptor affinity, and mammary tumor inhibiting properties. J Med Chem (1982) 0.80
Differential expression of the growth hormone receptor and its transcript in bovine uterus and placenta. Mol Cell Endocrinol (1997) 0.80
Progesterone antagonists: tumor-inhibiting potential and mechanism of action. J Steroid Biochem Mol Biol (1992) 0.79